The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) have awarded the Herbert A. Fleisch ESCEO-IOF Medal to leading Italian geriatrician Professor Antonio Cherubini. The Award was presented by IOF President Cyrus Cooper at the opening of the virtual World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

The Herbert A. Fleisch ESCEO-IOF Medal recognizes a researcher who has made outstanding and ground-breaking achievements in basic bone science or musculoskeletal research. It is named after the late Professor Herbert Fleisch, whose pioneering work contributed to the development of the field of scientific knowledge about metabolic bone diseases and their treatment.

ESCEO President Professor Jean-Yves Reginster, stated:

“ESCEO and IOF are honoured to present this prestigious Award to Professor Antonio Cherubini, a leading geriatrician and clinical researcher who has made outstanding contributions to the broader field of ageing and clinical geriatrics. He is an internationally respected investigator and author who is highly deserving of this year’s ESCEO-IOF Herbert Fleisch Medal.”

Professor Cherubini is Chief, Geriatria Accettazione Geriatrica e Centro di Ricerca per l’Invecchiamento, Geriatric Hospital, IRCCS-INRCA, Ancona, Italy and Associate Professor of Gerontology and Geriatrics, Perugia University Medical School. He is a member of major Italian and European societies in the field of geriatrics, including the European Union Geriatric Medicine Society (EUGMS) for which he is currently Academic Director (2022-2023). He has been a member of the Geriatric Expert Group of the European Medicine Agency since 2011.

Professor Cherubini’s areas of research include the role of antioxidants and micronutrients in ageing; age-related diseases (stroke, atherosclerosis, dementia, osteoporosis, sarcopenia) and frailty; geriatric depression; comprehensive geriatric assessment in nursing home residents; stroke in older people; benefits of physical activity in the elderly; pharmacotherapy in the older patient, exclusion of older people from clinical trials; inappropriate prescription; delirium; and sarcopenia and frailty.

He has carried out research internationally, including as principal investigator in several regional and national research projects as well as project leader or collaborator in European projects including Predict, Profound, Senator, and Sprint-t, among others. Professor Cherubini is the author of more than 400 papers in peer-reviewed journals, author of five books in Italian as well as several international and national books or book chapters. Among his many editorial activities, he is Associate Editor of European Geriatric Medicine, Editor of the geriatric section of Panminerva medica, and he serves on the editorial boards of the journals Aging, Clinical Exp Research, Journal of Frailty and Aging, and Journal of Gerontology and Geriatrics.


About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO)

Held jointly by IOF and ESCEO, the WCO-IOF-ESCEO annual congress is the world’s largest forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including osteoporosis, osteoarthritis, sarcopenia, and frailty. The WCO-IOF-ESCEO 2022 is held as a virtual Congress. The WCO-IOF-ESCO 2023 is planned from May 4-7, 2023 in Barcelona, Spain.

For complete information visit


The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policymakers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis, and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as more than patient, medical and research organizations, work together to make fracture prevention and healthy mobility a worldwide heath care priority.   @iofbonehealth